In vivo pharmacodynamic activity of daptomycinSAFDAR, Nasia; ANDES, David; CRAIG, W. A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 63-68, issn 0066-4804, 6 p.Article

EUCAST Technical Note on daptomycinClinical microbiology and infection. 2006, Vol 12, Num 6, pp 599-601, issn 1198-743X, 3 p.Article

Genetically Engineered Lipopeptide Antibiotics Related to A54145 and Daptomycin with Improved PropertiesNGUYEN, Kien T; XIAOWEI HE; BRIAN, Paul et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 4, pp 1404-1413, issn 0066-4804, 10 p.Article

DaptomycinENOCH, David A; BYGOTT, Jeanine M; DALY, Marie-Louise et al.The Journal of infection. 2007, Vol 55, Num 3, pp 205-213, issn 0163-4453, 9 p.Article

Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organismsSTREIT, Jennifer M; JONES, Ronald N; SADER, Helio S et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 4, pp 669-674, issn 0305-7453, 6 p.Article

Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MDEISENSTEIN, Barry I; OLESON, Frederick B; BALTZ, Richard H et al.Clinical infectious diseases. 2010, Vol 50, issn 1058-4838, S10-S15, SUP1Conference Paper

A Current Perspective on Daptomycin for the Clinical MicrobiologistHUMPHRIES, Romney M; POLLETT, Simon; SAKOULAS, George et al.Clinical microbiology reviews (Print). 2013, Vol 26, Num 4, pp 759-780, issn 0893-8512, 22 p.Article

Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamberHALL, Emily W; ROUSE, Mark S; JACOFSKY, David J et al.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 4, pp 261-265, issn 0732-8893, 5 p.Article

Lysyl-Phosphatidylglycerol Attenuates Membrane Perturbation Rather than Surface Association of the Cationic Antimicrobial Peptide 6W-RP-1 in a Model Membrane System: Implications for Daptomycin ResistanceKILELEE, Erin; POKORNY, Antje; YEAMAN, Michael R et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 10, pp 4476-4479, issn 0066-4804, 4 p.Article

Antimicrobial update : DaptomycinOBERHOLZER, Christopher M; CASERTA, Mary T.The Pediatric infectious disease journal. 2005, Vol 24, Num 10, pp 919-920, issn 0891-3668, 2 p.Article

Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agarJOHNSON, Alan P; MUSHTAQ, Shazad; WARNER, Marina et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 5, pp 860-862, issn 0305-7453, 3 p.Article

Emergence of daptomycin-non-susceptible enterococci urinary tract isolatesKELESIDIS, Theodoros; HUMPHRIES, Romney; CHOW, Angela L. P et al.Journal of medical microbiology. 2013, Vol 62, Num 7, pp 1103-1105, issn 0022-2615, 3 p.Article

Prospective, Open-Label Investigation of the Pharmacokinetics of Daptomycin during Cardiopulmonary Bypass SurgeryNGUYEN, Megan H; EELLS, Samantha J; TAN, Jennifer et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 6, pp 2499-2505, issn 0066-4804, 7 p.Article

Activity of Daptomycin against Listeria monocytogenes Isolates from Cerebrospinal FluidSPANJAARD, Lodewijk; VANDENBROUCKE-GRAULS, Christina M. J. E.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 5, pp 1850-1851, issn 0066-4804, 2 p.Article

Mechanisms of Resistance to Daptomycin in Enterococcus faeciumMONTERO, Clemente I; STOCK, Frida; MURRAY, Patrick R et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 3, pp 1167-1170, issn 0066-4804, 4 p.Article

Non-ribosomal peptide synthetase module fusions to produce derivatives of daptomycin in Streptomyces roseosporusDOEKEL, Sascha; COËFFET-LE GAL, Marie-Francoise; GU, Jian-Qiao et al.Microbiology (Reading). 2008, Vol 154, pp 2872-2880, issn 1350-0872, 9 p., 9Article

Treatment failure resulting from resistance of Staphylococcus aureus to daptomycinSKIEST, Daniel J.Journal of clinical microbiology (Print). 2006, Vol 44, Num 2, pp 655-656, issn 0095-1137, 2 p.Article

Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for CliniciansKELESIDIS, Theodoros; HUMPHRIES, Romney; USLAN, Daniel Z et al.Clinical infectious diseases. 2011, Vol 52, Num 2, pp 228-234, issn 1058-4838, 7 p.Article

The efficacy and safety of daptomycin vs. ec Editor's Choice vancomycin for the treatment of cellulitis and erysipelasPERTEL, P. E; EISENSTEIN, B. I; LINK, A. S et al.International journal of clinical practice (Esher). 2009, Vol 63, Num 3, pp 368-375, issn 1368-5031, 8 p.Article

Outpatient parenteral antibiotic therapy with daptomycin : insights from a patient registryMARTONE, W. J; LINDFIELD, K. C; KATZ, D. E et al.International journal of clinical practice (Esher). 2008, Vol 62, Num 8, pp 1183-1187, issn 1368-5031, 5 p.Article

Clinical experience with daptomycin for the treatment of patients with osteomyelitisLAMP, Kenneth C; FRIEDRICH, Lawrence V; MENDEZ-VIGO, Luke et al.The American journal of medicine. 2007, Vol 120, Num 10, issn 0002-9343, S13-S20, SUPAArticle

Daptomycin in the treatment of bacteremiaSAKOULAS, George; GOLAN, Yoav; LAMP, Kenneth C et al.The American journal of medicine. 2007, Vol 120, Num 10, issn 0002-9343, S21-S27, SUPAArticle

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteersBENVENUTO, Mark; BENZIGER, David P; YANKELEV, Sara et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 10, pp 3245-3249, issn 0066-4804, 5 p.Article

Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwideSADER, Helio S; STREIT, Jennifer M; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 3, pp 201-204, issn 0732-8893, 4 p.Article

Genetic Basis for In Vivo Daptomycin Resistance in EnterococciARIAS, Cesar A; PANESSO, Diana; REYES, Jinnethe et al.The New England journal of medicine. 2011, Vol 365, Num 10, pp 892-900, issn 0028-4793, 9 p.Article